LTRN · Lantern Pharma Inc. · Analyst Estimates
$1.71
-0.05 (-2.84%)
At close · Sep 11
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern in the absence of obtaining substantial additional funding. While the Company plans to pursue periodic capital raises, including additional potential sales under the ATM, as well as potential collaborations, grant funding and other opportunities to extend the Company's operating runway, no assurance can be given that sufficient funding will be available when needed to allow the Company to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$21.86M
Shares
12.78M
Analyst Estimates
Compare analyst forecasts for Lantern Pharma Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
No analyst consensus was found on the examined investor-relations pages. Coverage is not market-wide.
No published consensus found
No analyst consensus was found on the examined investor-relations pages. Coverage is not market-wide.
Key facts
CIK
1763950
CUSIP
51654W101
13F (30d)
16 filings
16 filers
Visit website
Investor relations